Receptor for hyaluronan‐mediated motility ( <scp>RHAMM</scp> ) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patientsSarah E Tarullo, Andrew C. Nelson|The Journal of Pathology|2023Cited by 18